Targeted proteomics improves cardiovascular risk prediction in secondary prevention

AIMS: Current risk scores do not accurately identify patients at highest risk of recurrent atherosclerotic cardiovascular disease (ASCVD) in need of more intensive therapeutic interventions. Advances in high-throughput plasma proteomics, analysed with machine learning techniques, may offer new oppor...

Full description

Bibliographic Details
Main Authors: Belo Pereira, J.P (Author), Bom, M.J (Author), Catapano, A.L (Author), de Kleijn, D. (Author), Hoefer, I.E (Author), Hoogeveen, R.M (Author), Knaapen, P. (Author), Koenig, W. (Author), Kraaijenhof, J.M (Author), Kroon, J. (Author), Levin, E. (Author), Nurmohamed, N.S (Author), Stroes, E.S.G (Author), Timmerman, N. (Author), Visseren, F.L.J (Author), Waissi, F. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Online Access:View Fulltext in Publisher

Similar Items